13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q1 2024. See the latest, Q2 2026 →
Reported value
$441.98B
+8.7% on the quarter before
Positions
410
27 new · 25 sold out
Top 10
32.3%
of the value
Est. gain
+$38.57B
on stocks held all quarter
Est. return
+10.2%
on those stocks since Q4 2023
Positions as of Mar 31, 2024, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 49% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2023. Striped tiles are options.
Largest buys
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Flutter Entmt Plc~$2.42BNew · 0.0% → 0.5%+12,243,822 shares
- Meta~$2.13BAdded · 2.6% → 3.8%+4,379,826 shares
- Capital One Finl Corp~$1.33BAdded · 0.4% → 0.7%+8,900,241 shares
- Amazon~$1.23BAdded · 3.0% → 3.5%+6,810,145 shares
- Alphabet~$1.10BAdded · 1.7% → 2.0%+7,275,757 shares
- Air Prods & Chems Inc~$1.04BAdded · 0.5% → 0.6%+4,309,040 shares
- Salesforce~$917.0MAdded · 0.7% → 1.0%+3,044,611 shares
- Vertex Pharmaceuticals Inc~$909.7MAdded · 0.4% → 0.5%+2,176,218 shares
- Jpmorgan Chase & Co~$651.5MAdded · 0.6% → 0.8%+3,252,451 shares
- Mcdonalds Corp~$618.5MAdded · 0.2% → 0.3%+2,193,769 shares
Largest sells
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Marvell Technology Inc~$2.39BCut · 0.5% → 0.0%−33,729,730 shares
- Intel~$1.51BCut · 0.9% → 0.3%−34,106,783 shares
- Pg&E Corp~$1.12BCut · 0.4% → 0.0%−66,735,916 shares
- Unitedhealth Group Inc~$973.4MCut · 2.0% → 1.5%−1,967,721 shares
- Humana Inc~$916.6MSold out · 0.2% → 0.0%−2,002,097 shares
- Comcast Corp New~$911.3MCut · 0.7% → 0.4%−21,020,971 shares
- General Electric Co~$762.2MCut · 2.6% → 3.1%−4,342,331 shares
- Netflix~$725.1MCut · 0.8% → 0.8%−1,193,992 shares
- Morgan Stanley~$642.3MCut · 0.4% → 0.2%−6,821,626 shares
- Cme Group Inc~$635.3MCut · 0.3% → 0.2%−2,951,040 shares
Holdings
As of Mar 31, 2024. Changes are in shares against Dec 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +0.01% · price +11.9% | 7.4% | $32.90B | +$3.49B | ||||||||
| BroadcomCOM · shares −2.1% · price +18.7% | 5.2% | $23.11B | +$3.65B | ||||||||
| MetaCL A · shares +14% · price +37.2% | 3.8% | $16.80B | +$3.98B | ||||||||
| AmazonCOM · shares +8.5% · price +18.7% | 3.5% | $15.69B | +$2.28B | ||||||||
| General Electric CoCOM NEW · shares −5.2% · price +37.5% | 3.1% | $13.82B | +$3.77B | ||||||||
| Abbott LabsCOM · shares −3.0% · price +3.3% | 2.2% | $9.55B | +$301.5M | ||||||||
| Rtx CorporationCOM · shares +4.2% · price +15.9% | 2.1% | $9.19B | +$1.21B | ||||||||
| AlphabetCAP STK CL A · shares +14% · price +8.0% | 2.0% | $8.72B | +$567.9M | ||||||||
| MastercardCL A · shares +0.3% · price +12.9% | 1.5% | $6.57B | +$749.3M | ||||||||
| Unitedhealth Group IncCOM · shares −13% · price −6.0% | 1.5% | $6.51B | −$417.9M | ||||||||
| Eli LillyCOM · shares +6.0% · price +33.5% | 1.4% | $6.25B | +$1.48B | ||||||||
| Canadian Nat Res LtdCOM · shares −5.6% · price +16.4% | 1.4% | $6.01B | +$848.3M | ||||||||
| NvidiaCOM · shares −2.2% · price +82.5% | 1.3% | $5.86B | +$2.65B | ||||||||
| Abbvie IncCOM · shares +3.3% · price +17.5% | 1.3% | $5.70B | +$822.1M | ||||||||
| Philip Morris Intl IncCOM · shares +3.1% · price −2.6% | 1.2% | $5.52B | −$143.7M | ||||||||
| AppleCOM · shares +0.2% · price −10.9% | 1.2% | $5.45B | −$667.9M | ||||||||
| AlphabetCAP STK CL C · shares +2.0% · price +8.0% | 1.2% | $5.41B | +$395.1M | ||||||||
| Carrier GlobalCOM · shares −0.5% · price +1.2% | 1.2% | $5.37B | +$62.8M | ||||||||
| Home Depot IncCOM · shares −8.6% · price +10.7% | 1.2% | $5.18B | +$500.0M | ||||||||
| Texas InstrumentsCOM · shares +4.7% · price +2.2% | 1.1% | $5.00B | +$102.9M | ||||||||
| GE HealthCareCOMMON STOCK · shares +5.2% · price +17.6% | 1.1% | $4.91B | +$697.8M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +1.5% · price +9.5% | 1.1% | $4.72B | +$402.8M | ||||||||
| United Rentals IncCOM · shares −0.6% · price +25.8% | 1.0% | $4.59B | +$939.9M | ||||||||
| Linde PlcSHS · shares −6.1% · price +13.1% | 1.0% | $4.53B | +$522.7M | ||||||||
| Gilead Sciences IncCOM · shares +2.7% · price −9.6% | 1.0% | $4.49B | −$462.9M | ||||||||
| Total · 410 positions | 100% | $441.98B | +$38.57B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2023 to Q1 2024: 383 stocks held throughout, up $38.57B (+10.2%).
- Meta+$3.98B+37%
- General Electric Co+$3.77B+38%
- Broadcom+$3.65B+19%
- Microsoft+$3.49B+12%
- Nvidia+$2.65B+82%
- Unitedhealth Group Inc−$417.9M−6%
- Gilead Sciences Inc−$462.9M−10%
- Apple−$667.9M−11%
- Old Dominion Freight Line In−$771.2M−46%
- Boeing Co−$1.11B−26%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |